Design of multi-binding-site inhibitors, ligand efficiency, and consensus screening of avian influenza H5N1 wild-type neuraminidase and of the oseltamivir-resistant H274Y variant - PubMed
. 2008 Oct;48(10):2074-80.
doi: 10.1021/ci800242z. Epub 2008 Oct 11.
Affiliations
- PMID: 18847186
- DOI: 10.1021/ci800242z
Design of multi-binding-site inhibitors, ligand efficiency, and consensus screening of avian influenza H5N1 wild-type neuraminidase and of the oseltamivir-resistant H274Y variant
Alfonso T García-Sosa et al. J Chem Inf Model. 2008 Oct.
Abstract
The binding sites of wild-type avian influenza A H5N1 neuraminidase, as well as those of the Tamiflu (oseltamivir)-resistant H274Y variant, were explored computationally to design inhibitors that target simultaneously several adjacent binding sites of the open conformation of the virus protein. The compounds with the best computed free energies of binding, in agreement by two docking methods, consensus scoring, and ligand efficiency values, suggest that mimicking a polysaccharide, beta-lactam, and other structures, including known drugs, could be routes for multibinding site inhibitor design. This new virtual screening method based on consensus scoring and ligand efficiency indices is introduced, which allows the combination of pharmacodynamic and pharmacokinetic properties into unique measures.
Similar articles
-
Design of oseltamivir analogs inhibiting neuraminidase of avian influenza virus H5N1.
Rungrotmongkol T, Frecer V, De-Eknamkul W, Hannongbua S, Miertus S. Rungrotmongkol T, et al. Antiviral Res. 2009 Apr;82(1):51-8. doi: 10.1016/j.antiviral.2009.01.008. Epub 2009 Feb 6. Antiviral Res. 2009. PMID: 19428595
-
Park JW, Jo WH. Park JW, et al. J Chem Inf Model. 2009 Dec;49(12):2735-41. doi: 10.1021/ci900348n. J Chem Inf Model. 2009. PMID: 19957991
-
Source of oseltamivir resistance in avian influenza H5N1 virus with the H274Y mutation.
Malaisree M, Rungrotmongkol T, Nunthaboot N, Aruksakunwong O, Intharathep P, Decha P, Sompornpisut P, Hannongbua S. Malaisree M, et al. Amino Acids. 2009 Oct;37(4):725-32. doi: 10.1007/s00726-008-0201-z. Epub 2008 Nov 12. Amino Acids. 2009. PMID: 19002747
-
Influenza virus susceptibility and resistance to oseltamivir.
Aoki FY, Boivin G, Roberts N. Aoki FY, et al. Antivir Ther. 2007;12(4 Pt B):603-16. Antivir Ther. 2007. PMID: 17944268 Review.
-
Neuraminidase inhibitors and their role in avian and pandemic influenza.
Crusat M, de Jong MD. Crusat M, et al. Antivir Ther. 2007;12(4 Pt B):593-602. Antivir Ther. 2007. PMID: 17944267 Review.
Cited by
-
Anti-aggregating effect of the naturally occurring dipeptide carnosine on aβ1-42 fibril formation.
Aloisi A, Barca A, Romano A, Guerrieri S, Storelli C, Rinaldi R, Verri T. Aloisi A, et al. PLoS One. 2013 Jul 3;8(7):e68159. doi: 10.1371/journal.pone.0068159. Print 2013. PLoS One. 2013. PMID: 23844165 Free PMC article.
-
Recent progress in structure-based anti-influenza drug design.
Du J, Cross TA, Zhou HX. Du J, et al. Drug Discov Today. 2012 Oct;17(19-20):1111-20. doi: 10.1016/j.drudis.2012.06.002. Epub 2012 Jun 13. Drug Discov Today. 2012. PMID: 22704956 Free PMC article. Review.
-
Weight AK, Haldar J, Alvarez de Cienfuegos L, Gubareva LV, Tumpey TM, Chen J, Klibanov AM. Weight AK, et al. J Pharm Sci. 2011 Mar;100(3):831-5. doi: 10.1002/jps.22338. Epub 2010 Aug 25. J Pharm Sci. 2011. PMID: 20740680 Free PMC article.
-
Systematic exploration of multiple drug binding sites.
Bálint M, Jeszenői N, Horváth I, van der Spoel D, Hetényi C. Bálint M, et al. J Cheminform. 2017 Dec 28;9(1):65. doi: 10.1186/s13321-017-0255-6. J Cheminform. 2017. PMID: 29282592 Free PMC article.
-
Molecular dynamics directed CoMFA studies on carbocyclic neuraminidase inhibitors.
Chavan S, Bhayye S, Sobhia ME. Chavan S, et al. Mol Divers. 2011 Nov;15(4):979-87. doi: 10.1007/s11030-011-9332-3. Epub 2011 Sep 16. Mol Divers. 2011. PMID: 21922291
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical